JP2024521987A5 - - Google Patents

Info

Publication number
JP2024521987A5
JP2024521987A5 JP2023568539A JP2023568539A JP2024521987A5 JP 2024521987 A5 JP2024521987 A5 JP 2024521987A5 JP 2023568539 A JP2023568539 A JP 2023568539A JP 2023568539 A JP2023568539 A JP 2023568539A JP 2024521987 A5 JP2024521987 A5 JP 2024521987A5
Authority
JP
Japan
Prior art keywords
amino acid
sequence
acid length
cdr3
knob
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023568539A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024521987A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/028864 external-priority patent/WO2022241058A1/en
Publication of JP2024521987A publication Critical patent/JP2024521987A/ja
Publication of JP2024521987A5 publication Critical patent/JP2024521987A5/ja
Pending legal-status Critical Current

Links

JP2023568539A 2021-05-12 2022-05-11 ジスルフィド結合した結合ポリペプチドのスクリーニング及び発現の方法 Pending JP2024521987A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163187931P 2021-05-12 2021-05-12
US63/187,931 2021-05-12
US202163288992P 2021-12-13 2021-12-13
US63/288,992 2021-12-13
PCT/US2022/028864 WO2022241058A1 (en) 2021-05-12 2022-05-11 Methods of screening and expression of disulfide-bonded binding polypeptides

Publications (2)

Publication Number Publication Date
JP2024521987A JP2024521987A (ja) 2024-06-05
JP2024521987A5 true JP2024521987A5 (https=) 2025-05-19

Family

ID=82321343

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023568539A Pending JP2024521987A (ja) 2021-05-12 2022-05-11 ジスルフィド結合した結合ポリペプチドのスクリーニング及び発現の方法

Country Status (8)

Country Link
US (1) US20240218052A1 (https=)
EP (1) EP4337690A1 (https=)
JP (1) JP2024521987A (https=)
KR (1) KR20240007256A (https=)
AU (1) AU2022272307A1 (https=)
CA (1) CA3218571A1 (https=)
IL (1) IL308087A (https=)
WO (1) WO2022241058A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023379740A1 (en) * 2022-11-16 2025-05-29 Applied Biomedical Science Institute Fusion polypeptides and binding peptides and methods for producing and using same
WO2024123627A1 (en) * 2022-12-05 2024-06-13 Pelican Technology Holdings, Inc. Methods for expression of fusion-free bovine ultralong cdr3 scaffold

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571613B1 (en) 1991-12-13 2003-09-17 Xoma Corporation Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
BR112012025678A2 (pt) 2010-04-09 2017-07-18 Immuron Ltd composição para inibição da transmissão do hiv, uso da mesma, métood para preparação da mesma e método para inibição de transmissão do hiv.
CA2863224A1 (en) * 2012-01-09 2013-07-18 The Scripps Research Institute Ultralong complementarity determining regions and uses thereof
WO2015017146A2 (en) * 2013-07-18 2015-02-05 Fabrus, Inc. Antibodies with ultralong complementarity determining regions
CA2918370A1 (en) * 2013-07-18 2015-01-22 Fabrus, Inc. Humanized antibodies with ultralong complementarity determining regions
US10093720B2 (en) 2014-06-11 2018-10-09 International Aids Vaccine Initiative Broadly neutralizing antibody and uses thereof
CN112566650A (zh) 2018-06-21 2021-03-26 沙塔克实验室有限公司 异二聚体蛋白及其用途
IL296732A (en) * 2020-03-27 2022-11-01 UCB Biopharma SRL Autonomous knob domain peptides

Similar Documents

Publication Publication Date Title
CN106243226B (zh) 抗人ifnar1的抗体及其用途
CN108137685B (zh) 由体细胞突变基因编码的hla限制性表位
JP4992068B2 (ja) 超高親和性中和抗体
CN108251431B (zh) 双载体系统及其用途
TWI585104B (zh) 基於vl和vhh可變區衍生物的高親和力抗聚集抗體
CN112851804B (zh) 一种人源抗新型冠状病毒(SARS-CoV-2)的中和活性单克隆抗体
US20080038256A1 (en) Anti-hgf/sf humanized antibody and method for the preparation thereof
TWI801425B (zh) Il-5 抗體、其抗原結合片段及醫藥用途
JP2024521987A5 (https=)
TWI906795B (zh) 特異性結合Claudin 18.2的抗體及其製法和應用
CN113862300A (zh) 具有共同轻链的转基因兔
CN115746144B (zh) 抗tigit-pd1双特异性抗体及其应用
KR20240007256A (ko) 이황화 결합된 결합 폴리펩타이드의 스크리닝 및 발현 방법
CN113527474A (zh) 一种抗新冠病毒n蛋白的单克隆抗体及其应用
JP2023535233A (ja) グリコシル化ceacam5に特異的に結合した抗体
EP1616885B1 (en) Recombinant antibody recognizing dioxin and gene encoding the antibody
CN111892657B (zh) 用于检测米田堡血型抗原的抗体及其片段、试剂盒及方法
CN115975020A (zh) 靶向sars-cov-2s蛋白的抗原结合蛋白及其应用
CN117545768A (zh) 二硫键结合的结合多肽的筛选和表达的方法
CN118684767B (zh) 一种丙肝核心抗原单链抗体及其制备方法与应用
CN118652329B (zh) 一种抗非洲猪瘟病毒蛋白抗体及其用途
CN113150155B (zh) 一种抗pd-l1人源化单克隆抗体及其应用
CN119285786B (zh) 一种抗fap的纳米抗体及其应用
CN115433278A (zh) 结合cs1蛋白兔重组单克隆抗体及应用
CN116836268A (zh) 针对新型冠状病毒SARS-CoV-2的抗体及其用途